Clinical Trials List
2022-10-01 - 2028-06-22
Phase III
Recruiting8
ICD-10B37.0
Candidal stomatitis
ICD-10B37.83
Candidal cheilitis
ICD-9112.0
Candidiasis of mouth
xxxxxx
-
Trial Applicant
TAIWAN PSI HEALTH DEVELOPMENT COMPANY LIMITED
-
Sponsor
xxxxxx
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 高冠鈞 Division of Infectious Disease
- Hsin-Yi Liu Division of Infectious Disease
- Sheng-Yu Chen Division of Infectious Disease
- 黃筱雯 Division of Infectious Disease
- 莊涵琄 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ping-Feng Wu Division of Infectious Disease
- 陳昕白 Division of Infectious Disease
- 劉思妤 無
- Chien Chuang Division of Infectious Disease
- Chih Han Juan Division of Infectious Disease
- Chia-Jen Liu Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 謝顯森 Division of Infectious Disease
- Peng-Hao Chang Division of Infectious Disease
- 劉仲淇 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yu-Chao Lin Division of Infectious Disease
- Ho Mao-Wang Division of Infectious Disease
- 鄭孟瑜 無
- 陳智皓 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Yuan Lee 無
- Chau-Chyun Sheu 無
- Chung-Hao Huang 無
- Hui-Hua Hsiao 無
- Shih-Feng Cho 無
- 張雅婷 Division of Infectious Disease
- 陳家閔 無
- 蔡毓德 Division of Infectious Disease
- Yi-Chang Liu 無
- Wei-An Chang Division of Thoracic Medicine
- Tun-Chieh Chen 無
- Jeng-Shiun Du 無
- Shang-Yi Lin 無
- Yen-Hsu Chen Division of Infectious Disease
- Ming-Ju Tsai 無
- 羅世豪 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
048
110
048
130
Dosage
20 mg/mL
400 mg
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
450 participants